Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 853
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 
     

    Article Cited by others

SYMPOSIUM

Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention

Khurana Sumeeta, Batra Nitya

Year : 2016| Volume: 6| Issue : 2 | Page no: 123-128

   This article has been cited by
 
1 Serological and molecular screening of umbilical cord blood for Toxoplasma gondii infection
Eman F. Botein,Ahmad Darwish,Nora L. El-Tantawy,Rizk EL-baz,Mohamed I. Eid,Ali M Shaltot
Transplant Infectious Disease. 2019; : e13117
[Pubmed]  [Google Scholar] [DOI]
2 Case of cerebral toxoplasmosis masquerading as high-grade glioma
Kathleen P. McKenzie,Winnifred M. Wong,Shane B. Patterson,Joseph H. McDermott,Narayana K. Swamy,Claire L. Hiles
Interdisciplinary Neurosurgery. 2019; 17: 57
[Pubmed]  [Google Scholar] [DOI]
3 Management of toxoplasmosis in transplant recipients: an update
Céline Dard,Pierre Marty,Marie-Pierre Brenier-Pinchart,Cécile Garnaud,Hélène Fricker-Hidalgo,Hervé Pelloux,Christelle Pomares
Expert Review of Anti-infective Therapy. 2018; 16(6): 447
[Pubmed]  [Google Scholar] [DOI]
4 TgDrpC, an atypical dynamin-related protein in Toxoplasma gondii, is associated with vesicular transport factors and parasite division
Irene Heredero-Bermejo,Joseph M. Varberg,Robert Charvat,Kylie Jacobs,Tamila Garbuz,William J. Sullivan,Gustavo Arrizabalaga
Molecular Microbiology. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Approach to Transplant Infectious Diseases in the Emergency Department
Diana Zhong,Stephen Y. Liang
Emergency Medicine Clinics of North America. 2018;
[Pubmed]  [Google Scholar] [DOI]
6 In deep: cerebral toxoplasmosisRunning Head: Cerebral Toxoplasmosis in Immunocompromised Host
Melanie R.F. Greenway,Keith A. Sacco,M. Caroline Burton
The American Journal of Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 Mast cell activator compound 48/40 is not an effective adjuvant for UV-attenuated Toxoplasma gondii vaccine
Xi Li,Shengjie Chen,Shiguang Huang,Fangli Lu
Parasitology Research. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article